Jersey Shore University Medical Center Implants the World’s Smallest...
Jersey Shore University Medical Center Implants the World’s Smallest Pacemaker.

News • Micra TPS

The world’s smallest pacemaker

Jersey Shore University Medical Center, part of Meridian CardioVascular Network, is the first hospital in New Jersey to implant the Micra® Transcatheter Pacing System (TPS) – the world’s smallest pacemaker – since the device gained U.S. Food and Drug Administration (FDA) approval in April 2016.

Micra TPS is a new type of heart device that treats patients with bradycardia, a common heart condition characterized by a slow or irregular heart rhythm.

Procedures with the advanced pacing technology were performed at Jersey Shore by electrophysiologists Edmund Karam, M.D. and Mark Mascarenhas, M.D. to treat multiple patients with bradycardia. People with bradycardia usually experience fewer than 60 beats per minute. At this rate, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, shortness of breath or fainting spells. Pacemakers are the most common way to treat bradycardia to help restore the heart's normal rhythm and relieve symptoms by sending electrical impulses to the heart to increase the heart rate.

At one-tenth the size of a traditional pacemaker, Micra TPS is the only leadless pacemaker approved for use in the U.S. The minimally-invasive procedure takes less than an hour, and unlike traditional pacemakers – is not visible.

Comparable in size to a large vitamin, the device does not require cardiac wires (leads) or a surgical “pocket” under the skin to deliver a pacing therapy. Instead, the device is small enough to be delivered through a catheter and implanted directly into the heart with small tines, providing a safe alternative to conventional pacemakers. It also automatically adjusts pacing therapy based on a patient’s activity levels. For patients who need more than one heart device, the device has a unique feature that enables it to be permanently turned off so it can remain in the body and a new device can be implanted without risk of electrical interaction.


Source: Meridian Health

27.06.2016

Related articles

Photo

News • Irregular heartbeat treatment

Holograms help physicians during cardiac procedures

Bringing a little bit of science fiction into an operating room, a team of engineers and physicians at Washington University in St. Louis has shown for the first time that using a holographic display…

Photo

News • Multi-component procedure

SULEEI: extending the functional lives of biological heart valve prostheses

For decades now, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing processes and systems for cleaning, sterilization, and surface…

Photo

Article • Experts explore the future of CSP, CRT, ICD

Implantable cardiac devices: which techniques are ready for prime time?

Opposing views on new implantable cardiac devices were aired in a Great Debate session at the European Society of Cardiology’s annual 2024 congress in London. Experts discussed emerging techniques…

Related products

Subscribe to Newsletter